Literature DB >> 12710211

Pharmacogenetic analysis of clinically relevant genetic polymorphisms.

Christine M Rose1, Sharon Marsh, Margaret-Mary Ameyaw, Howard L McLeod.   

Abstract

Mesh:

Substances:

Year:  2003        PMID: 12710211     DOI: 10.1385/1-59259-380-1:225

Source DB:  PubMed          Journal:  Methods Mol Med        ISSN: 1543-1894


× No keyword cloud information.
  3 in total

1.  CYP2C8*3 predicts benefit/risk profile in breast cancer patients receiving neoadjuvant paclitaxel.

Authors:  Daniel L Hertz; Alison A Motsinger-Reif; Amy Drobish; Stacey J Winham; Howard L McLeod; Lisa A Carey; E Claire Dees
Journal:  Breast Cancer Res Treat       Date:  2012-04-18       Impact factor: 4.872

2.  Distribution of ITPA P32T alleles in multiple world populations.

Authors:  Sharon Marsh; Cristi R King; Ranjeet Ahluwalia; Howard L McLeod
Journal:  J Hum Genet       Date:  2004-08-21       Impact factor: 3.172

3.  CYP3A4 and CYP3A5 genotyping by Pyrosequencing.

Authors:  Adam A Garsa; Howard L McLeod; Sharon Marsh
Journal:  BMC Med Genet       Date:  2005-05-09       Impact factor: 2.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.